Table 2.
In vitro susceptibility testing of the Myroides odoratimimus isolates
Antibiotic | C1
|
C2
|
C3
|
C4
|
||||
---|---|---|---|---|---|---|---|---|
MIC value (µg/mL) | Interpretation (S, I, R) | MIC value (µg/mL) | Interpretation (S, I, R) | MIC value (µg/mL) | Interpretation (S, I, R) | MIC value (µg/mL) | Interpretation (S, I, R) | |
Ticarcillin | ≥128 | R | ≥128 | R | ≥128 | R | ≥128 | R |
Piperacillin | ≥128 | R | ≥128 | R | ≥128 | R | ≥128 | R |
Piperacillin/tazobactam | 64 | I | ≥128 | R | ≥128 | R | ≥128 | R |
Ceftazidime | ≥64 | R | ≥64 | R | ≥64 | R | ≥64 | R |
Cefepime | 32 | R | ≥64 | R | ≥64 | R | ≥64 | R |
Aztreonam | ≥64 | R | ≥64 | R | ≥64 | R | ≥64 | R |
Imipenem | ≥16 | R | ≥16 | R | ≥16 | R | ≥16 | R |
Meropenem | ≥16 | R | ≥16 | R | ≥16 | R | ≥16 | R |
Amikacin | ≥64 | R | ≥64 | R | ≥64 | R | ≥64 | R |
Gentamicin | ≥16 | R | ≥16 | R | ≥16 | R | ≥16 | R |
Tobramycin | ≥16 | R | ≥16 | R | ≥16 | R | ≥16 | R |
Ciprofloxacin | ≥4 | R | ≥4 | R | ≥4 | R | ≥4 | R |
Pefloxacin | 8 | R | 8 | R | 8 | R | ≥16 | R |
Minocycline | 2 | S | 2 | S | 2 | S | ≥1 | S |
Colistin | ≥16 | R | ≥16 | R | ≥16 | R | ≥16 | R |
Trimethoprim–sulfamethoxazole | ≥320 | R | ≥320 | R | ≥320 | R | ≥320 | R |
Abbreviations: I, intermediate; MIC, minimum inhibitory concentration; R, resistant; S, susceptible.